GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Pre-Tax Income

APLIF (Appili Therapeutics) Pre-Tax Income : $-2.89 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Appili Therapeutics's pretax income for the three months ended in Dec. 2024 was $-0.38 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.89 Mil. Appili Therapeutics's pretax margin was -493.42%.

During the past 7 years, Appili Therapeutics's highest Pretax Margin was -448.73%. The lowest was -3164.80%. And the median was -2262.32%.


Appili Therapeutics Pre-Tax Income Historical Data

The historical data trend for Appili Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Pre-Tax Income Chart

Appili Therapeutics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial -3.88 -11.40 -19.81 -6.73 -2.74

Appili Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.81 -1.16 -0.55 -0.38

Competitive Comparison of Appili Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Appili Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Appili Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Appili Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Appili Therapeutics's Pre-Tax Income falls into.


;
;

Appili Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Appili Therapeutics's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.598+0.049+-1.205+0.013+-0.00099999999999989
=-2.74

Appili Therapeutics's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=0.349+-0.357+-0.366+0+-0.001
=-0.38

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Appili Therapeutics  (OTCPK:APLIF) Pre-Tax Income Explanation

Appili Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.375/0.076
=-493.42%

During the past 7 years, Appili Therapeutics's highest Pretax Margin was -448.73%. The lowest was -3164.80%. And the median was -2262.32%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Appili Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Appili Therapeutics Business Description

Traded in Other Exchanges
Address
1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.